MCA presented a paper seeking the Commission's advice on "Disease awareness campaigns" by the pharmaceutical industry. There had already been some debate about this approach and discussion about whether or not it constituted advertising. The Commission's initial views were that there could be a major benefit to public health from such campaigns particularly where it results in greater awareness among the public. However, it appreciated that there could be risks and some campaigns were tantamount to advertising. It was agreed that a more detailed paper would be prepared by *, with input from *, for the next meeting.

	Contents page
	List of correspondence with MCA/CSM